| Cipla Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500087 |
NSE Symbol : CIPLA |
P/E(TTM) : 28.41 |
|
ISIN Demat : INE059A01026 |
Div & Yield% : 0.87 |
EPS(TTM) : 52.42 |
|
Book Value(₹) : 360.74 |
Market Cap(₹Cr) : 120,269.88 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 16,574.34 | 14,345.34 | 15,380.82 | 11,302.71 | 12,659.15 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 16,574.34 | 14,345.34 | 15,380.82 | 11,302.71 | 12,659.15 |
| Other Income | 1,433.72 | 826.20 | 742.05 | 653.91 | 892.85 |
| Stock Adjustments | -104.57 | -194.32 | 541.93 | -6.41 | 43.08 |
| Total Income | 17,903.49 | 14,977.22 | 16,664.80 | 11,950.21 | 13,595.08 |
| EXPENDITURE : | |||||
| Raw Materials | 4,977.62 | 4,739.89 | 6,467.54 | 4,097.20 | 4,362.29 |
| Power and Fuel Cost | 271.66 | 257.07 | 247.58 | 234.58 | 253.95 |
| Other Manufacturing Expenses | 1,243.47 | 988.99 | 994.55 | 906.09 | 921.04 |
| Selling and Administration Expenses | 2,510.53 | 2,334.97 | 2,107.17 | 1,578.59 | 2,093.92 |
| Miscellaneous Expenses | 338.13 | 327.42 | 272.66 | -291.15 | 452.66 |
| Employee Benefit Expenses | 2,644.21 | 2,335.69 | 2,122.02 | 1,703.58 | 1,911.08 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 5,917.87 | 3,993.19 | 4,453.28 | 3,721.32 | 3,600.14 |
| Interest | 20.25 | 22.27 | 26.93 | 45.07 | 36.05 |
| Gross Profit | 5,897.62 | 3,970.92 | 4,426.35 | 3,676.25 | 3,564.09 |
| Depreciation | 587.59 | 595.91 | 546.62 | 468.62 | 599.78 |
| Profit Before Tax | 5,310.03 | 3,375.01 | 3,879.73 | 3,207.63 | 2,964.31 |
| Current Tax | 1,226.69 | 901.63 | 949.49 | 756.27 | 545.96 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 6.09 | -40.09 | -27.69 | -16.92 | 100.18 |
| Reported Net Profit | 4,077.25 | 2,513.47 | 2,957.93 | 2,468.28 | 2,318.17 |
| Extraordinary Items | 42.92 | -41.59 | 48.88 | 39.09 | 91.40 |
| Adjusted Net Profit | 4,034.33 | 2,555.06 | 2,909.05 | 2,429.19 | 2,226.77 |
| Adjustment below Net Profit | -74.47 | -10.52 | 18.48 | 13.71 | -49.53 |
| Profit/Loss Balance carried down | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 | 10,828.56 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 686.17 | 403.50 | 403.35 | - | 617.48 |
| P & L Balance carried down | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 |
| Dividend | - | - | - | - | 322.49 |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 650.00 | 425.00 | 250.00 | 250.00 | 200.00 |
| Dividend Per Share(Rs) | 13.00 | 8.50 | 5.00 | 5.00 | 4.00 |
| Earnings Per Share-Unit Curr | 50.50 | 31.14 | 36.66 | 30.61 | 28.75 |
| Earnings Per Share(Adj)-Unit Curr | 50.50 | 31.14 | 36.66 | 30.61 | 28.75 |
| Book Value | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 |
| Book Value(Adj)-Unit Curr | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 |